|
Bain Capital Investors Llc
|
Non-Executive |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Koppel Adam
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Gordon Christopher R
|
Non-Executive Director |
Cerevel Therapeutics Holdings, Inc. (CERE)
|
2023-10-16 |
$22.81 |
97.1% |
$121,383,146
|
5,480,052
|
$124,999,986 |
|
Duggan Robert W
|
Non-Executive Director |
Pulse Biosciences, Inc. (PLSE)
|
2023-05-09 |
$6.51 |
168.5% |
$109,951,619
|
10,022,937
|
$65,249,320 |
|
Cormorant Asset Management, Lp
|
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-04-20 |
$11.30 |
147.7% |
$87,074,602
|
5,215,189
|
$58,950,690 |
|
Mfn Partners, Lp
|
Non-Executive |
RXO, Inc. (RXO)
|
2024-08-12 |
$20.21 |
34.9% |
$72,381,011
|
10,266,810
|
$207,492,230 |
|
Sarofim Christopher Binyon
|
Non-Executive Director |
Sable Offshore Corp. (SOC)
|
2024-02-14 |
$10.00 |
116.1% |
$69,660,006
|
6,000,000
|
$60,000,000 |
|
Viking Global Investors Lp
|
Non-Executive |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
$61,791,674
|
1,388,889
|
$25,000,002 |
|
Viking Global Investors Lp
|
Non-Executive |
RayzeBio, Inc. (RYZB)
|
2023-09-19 |
$18.00 |
247.2% |
$61,791,674
|
1,388,889
|
$25,000,002 |
|
Casdin Eli
|
Non-Executive Director |
GeneDx Holdings Corp. (WGS)
|
2023-01-31 |
$11.55 |
182.4% |
$54,727,270
|
2,597,403
|
$30,000,000 |
|
Longitude Capital Partners Iv, Llc
|
Non-Executive |
Vera Therapeutics, Inc. (VERA)
|
2023-02-06 |
$7.00 |
445.1% |
$53,417,121
|
1,714,285
|
$11,999,995 |
|
Enright Patrick G
|
Non-Executive Director |
Vera Therapeutics, Inc. (VERA)
|
2023-02-06 |
$7.00 |
445.1% |
$53,417,121
|
1,714,285
|
$11,999,995 |
|
Loews Corp
|
Non-Executive |
CNA FINANCIAL CORP (CNA)
|
2023-08-02 |
$39.29 |
30.4% |
$53,249,806
|
4,456,050
|
$175,078,204 |
|
Ra Capital Management, L.P.
|
Non-Executive Director |
Eliem Therapeutics, Inc. (ELYM)
|
2024-06-27 |
$3.84 |
97.1% |
$48,521,877
|
13,008,546
|
$49,952,817 |
|
Cormorant Asset Management, Lp
|
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-04-17 |
$9.75 |
187.3% |
$47,421,799
|
2,597,896
|
$25,319,289 |
|
Emanuel Ariel
|
Chief Executive Officer |
TKO Group Holdings, Inc. (TKO)
|
2024-04-09 |
$89.01 |
30.5% |
$44,655,928
|
1,642,970
|
$146,240,760 |
|
Whitesell Patrick
|
Non-Executive |
TKO Group Holdings, Inc. (TKO)
|
2024-04-09 |
$89.01 |
30.5% |
$44,655,928
|
1,642,970
|
$146,240,760 |
|
White Mountains Insurance Group Ltd
|
Non-Executive Director |
MediaAlpha, Inc. (MAX)
|
2023-06-30 |
$10.00 |
72.6% |
$42,956,084
|
5,916,816
|
$59,168,160 |
|
Cormorant Asset Management, Lp
|
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-09-18 |
$9.12 |
207.1% |
$40,651,063
|
2,152,738
|
$19,625,601 |
|
Telegraph Hill Partners Iv, L.P.
|
Non-Executive |
Alpha Teknova, Inc. (TKNO)
|
2024-07-12 |
$1.24 |
269.4% |
$40,403,222
|
12,096,773
|
$14,999,999 |
|
Flores James C
|
Chairman |
Sable Offshore Corp. (SOC)
|
2024-02-14 |
$10.01 |
115.9% |
$37,330,123
|
3,217,500
|
$32,200,055 |
|
Lantheus Alpha Therapy, Llc
|
Non-Executive |
Perspective Therapeutics, Inc. (CATX)
|
2024-03-06 |
$9.50 |
62.5% |
$35,896,037
|
6,043,104
|
$57,409,487 |
|
Stonehill Capital Management Llc
|
Non-Executive |
Veradigm Inc. (MDRX)
|
2024-03-01 |
$6.46 |
54.1% |
$35,716,106
|
10,222,875
|
$66,001,500 |
|
Reardon Tighe
|
Acting Chief Financial Officer |
Janux Therapeutics, Inc. (JANX)
|
2023-11-13 |
$5.87 |
644.6% |
$32,158,475
|
849,854
|
$4,988,643 |
|
Avalon Ventures Xi, L.P.
|
Non-Executive |
Janux Therapeutics, Inc. (JANX)
|
2023-11-13 |
$5.87 |
644.6% |
$32,158,475
|
849,854
|
$4,988,643 |
|
Lichter Jay
|
Non-Executive Director |
Janux Therapeutics, Inc. (JANX)
|
2023-11-13 |
$5.87 |
644.6% |
$32,158,475
|
849,854
|
$4,988,643 |
|
Sylebra Capital Ltd
|
Non-Executive |
IMPINJ INC (PI)
|
2023-08-11 |
$58.26 |
183.6% |
$28,209,631
|
263,740
|
$15,365,492 |
|
Perceptive Advisors Llc
|
Non-Executive |
SOLENO THERAPEUTICS INC (SLNO)
|
2023-09-28 |
$17.44 |
186.3% |
$28,151,858
|
866,789
|
$15,113,916 |
|
Kersten Dirk
|
Non-Executive Director |
Dyne Therapeutics, Inc. (DYN)
|
2024-01-09 |
$17.50 |
92.3% |
$27,685,706
|
1,714,285
|
$29,999,988 |
|
Cormorant Asset Management, Lp
|
Non-Executive |
Ambrx Biopharma, Inc. (AMAM)
|
2023-10-23 |
$6.99 |
300.5% |
$27,465,166
|
1,307,311
|
$9,139,542 |
|
Uber Technologies, Inc
|
Non-Executive |
Aurora Innovation, Inc. (AUR)
|
2023-07-21 |
$3.00 |
35.2% |
$26,399,999
|
25,037,036
|
$74,999,997 |
|
Cormorant Asset Management, Lp
|
Non-Executive |
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
|
2024-02-02 |
$19.00 |
167.2% |
$23,827,500
|
750,000
|
$14,250,000 |
|
Dejoria John Paul
|
Non-Executive |
HighPeak Energy, Inc. (HPK)
|
2023-07-19 |
$10.50 |
34.0% |
$23,459,998
|
6,571,428
|
$68,999,994 |
|
Sylebra Capital Ltd
|
Non-Executive |
IMPINJ INC (PI)
|
2023-08-15 |
$61.20 |
170.0% |
$23,423,432
|
225,182
|
$13,781,138 |
|
Icahn Carl C
|
Non-Executive |
Southwest Gas Holdings, Inc. (SWX)
|
2023-03-10 |
$60.12 |
16.6% |
$23,305,024
|
2,332,835
|
$140,250,040 |
|
Azzurro Capital Inc
|
Non-Executive |
TRAVELZOO (TZOO)
|
2022-12-30 |
$4.40 |
152.3% |
$22,847,000
|
3,410,000
|
$15,004,000 |
|
Bartel Ralph
|
Non-Executive |
TRAVELZOO (TZOO)
|
2022-12-30 |
$4.40 |
152.3% |
$22,847,000
|
3,410,000
|
$15,004,000 |
|
Telegraph Hill Partners Iv, L.P.
|
Non-Executive |
Alpha Teknova, Inc. (TKNO)
|
2023-09-19 |
$1.85 |
147.6% |
$22,135,132
|
8,108,107
|
$14,999,998 |
|
Blue Star Exploration Corp
|
Non-Executive |
COMSTOCK RESOURCES INC (CRK)
|
2024-03-25 |
$8.04 |
20.8% |
$20,925,000
|
12,500,000
|
$100,450,000 |
|
Chen Bihua
|
Non-Executive |
MoonLake Immunotherapeutics (MLTX)
|
2023-03-21 |
$20.28 |
124.7% |
$20,924,374
|
827,100
|
$16,774,846 |
|
Sylebra Capital Ltd
|
Non-Executive |
IMPINJ INC (PI)
|
2023-08-16 |
$60.02 |
175.3% |
$20,047,859
|
190,569
|
$11,437,951 |
|
Decheng Capital Global Healthcare Fund (Master), Lp
|
Non-Executive |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2023-11-09 |
$12.50 |
419.8% |
$19,676,250
|
375,000
|
$4,687,500 |
|
Cui Xiangmin
|
Non-Executive Director |
ALPINE IMMUNE SCIENCES, INC. (ALPN)
|
2023-11-09 |
$12.50 |
419.8% |
$19,676,250
|
375,000
|
$4,687,500 |
|
5Am Partners Vii, Llc
|
Non-Executive |
Skye Bioscience, Inc. (SKYE)
|
2024-01-31 |
$2.31 |
162.3% |
$19,522,778
|
5,206,074
|
$12,026,031 |
|
Levinson Sam
|
Non-Executive |
SONIDA SENIOR LIVING, INC. (SNDA)
|
2024-02-01 |
$9.50 |
192.2% |
$19,221,060
|
1,052,632
|
$10,000,004 |
|
Corvex Management Lp
|
Non-Executive |
Vestis Corp (VSTS)
|
2024-05-08 |
$9.96 |
53.5% |
$18,377,671
|
3,446,655
|
$34,321,684 |
|
Icahn School Of Medicine At Mount Sinai
|
Non-Executive |
GeneDx Holdings Corp. (WGS)
|
2023-01-31 |
$11.55 |
182.4% |
$18,242,423
|
865,801
|
$10,000,000 |
|
Cormorant Asset Management, Lp
|
Non-Executive |
Ambrx Biopharma Inc. (AMAM)
|
2023-03-16 |
$10.21 |
174.2% |
$17,788,600
|
1,000,000
|
$10,211,400 |
|
Ares Management Llc
|
Non-Executive |
Frontier Communications Parent, Inc. (FYBR)
|
2023-03-28 |
$21.13 |
65.7% |
$17,342,900
|
1,250,000
|
$26,407,100 |
|
Ares Management Llc
|
Non-Executive |
Frontier Communications Parent, Inc. (FYBR)
|
2023-03-28 |
$21.13 |
65.7% |
$17,342,900
|
1,250,000
|
$26,407,100 |